4 research outputs found

    Desarrollo de Materiales para Aplicaciones Marítimas, Fluviales y Militares

    Get PDF
    A platform to design composite materials of a polymeric matrix, that are specifically for military applications on fluvial and naval navigation, has been developed using energy dissipation and storage mechanisms. Our composites are designed to generate synergy between the dissipation capacities of ceramics and high-performance fibers, which are used as the reinforced material in the lightweight laminates. The composite design is combined with processing tools and advanced characterization techniques that result in laminates with reliability, traceability and quality. The platform begins with the identification of energy dissipation mechanisms and the detailed characterization of the polymeric resin. It includes the Time – Temperature – Transformation Diagram (TTT- Diagram) that supplies the optimal processing conditions. Our designs open new paths for military applications including a wide spectrum of protective systems together with geometric versatility, high mechanical resistance and reliabilityUtilizando los múltiples mecanismos de disipación de la energía de impacto a alta velocidad, hemos desarrollado una plataforma de diseño de materiales compuestos de matriz polimérica, especiales para aplicaciones militares en navegación fluvial y marítima.  Nuestros compuestos pretenden hacer sinergia entre las capacidades de disipación de cerámicos y fibras de alto desempeño, los cuales son utilizados como los elementos de refuerzo en los laminados de bajo peso.  El diseño del material es combinado con herramientas de procesamiento y técnicas avanzadas de caracterización que resultan en laminados consistentes de alta repetibilidad, trazabilidad y alta calidad.  La plataforma parte de la identificación de los mecanismos de disipación y de una caracterización detallada de la resina polimérica, el cual incluye un diagrama de Tiempo-Temperatura-Transformación que provee las condiciones óptimas de procesamiento.  Nuestros diseños abren rutas novedosas para aplicaciones militares, los cuales incluyen amplios portafolios de protección, versatilidad geométrica, resistencia mecánica y confiabilida

    Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

    Get PDF
    Background: We previously reported that impaired type I IFN activity, due to inborn errors of TLR3- and TLR7-dependent type I interferon (IFN) immunity or to autoantibodies against type I IFN, account for 15–20% of cases of life-threatening COVID-19 in unvaccinated patients. Therefore, the determinants of life-threatening COVID-19 remain to be identified in ~ 80% of cases. Methods: We report here a genome-wide rare variant burden association analysis in 3269 unvaccinated patients with life-threatening COVID-19, and 1373 unvaccinated SARS-CoV-2-infected individuals without pneumonia. Among the 928 patients tested for autoantibodies against type I IFN, a quarter (234) were positive and were excluded. Results: No gene reached genome-wide significance. Under a recessive model, the most significant gene with at-risk variants was TLR7, with an OR of 27.68 (95%CI 1.5–528.7, P = 1.1 × 10−4) for biochemically loss-of-function (bLOF) variants. We replicated the enrichment in rare predicted LOF (pLOF) variants at 13 influenza susceptibility loci involved in TLR3-dependent type I IFN immunity (OR = 3.70[95%CI 1.3–8.2], P = 2.1 × 10−4). This enrichment was further strengthened by (1) adding the recently reported TYK2 and TLR7 COVID-19 loci, particularly under a recessive model (OR = 19.65[95%CI 2.1–2635.4], P = 3.4 × 10−3), and (2) considering as pLOF branchpoint variants with potentially strong impacts on splicing among the 15 loci (OR = 4.40[9%CI 2.3–8.4], P = 7.7 × 10−8). Finally, the patients with pLOF/bLOF variants at these 15 loci were significantly younger (mean age [SD] = 43.3 [20.3] years) than the other patients (56.0 [17.3] years; P = 1.68 × 10−5). Conclusions: Rare variants of TLR3- and TLR7-dependent type I IFN immunity genes can underlie life-threatening COVID-19, particularly with recessive inheritance, in patients under 60 years old

    Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

    No full text
    BackgroundWe previously reported that impaired type I IFN activity, due to inborn errors of TLR3- and TLR7-dependent type I interferon (IFN) immunity or to autoantibodies against type I IFN, account for 15-20% of cases of life-threatening COVID-19 in unvaccinated patients. Therefore, the determinants of life-threatening COVID-19 remain to be identified in similar to 80% of cases.MethodsWe report here a genome-wide rare variant burden association analysis in 3269 unvaccinated patients with life-threatening COVID-19, and 1373 unvaccinated SARS-CoV-2-infected individuals without pneumonia. Among the 928 patients tested for autoantibodies against type I IFN, a quarter (234) were positive and were excluded.ResultsNo gene reached genome-wide significance. Under a recessive model, the most significant gene with at-risk variants was TLR7, with an OR of 27.68 (95%CI 1.5-528.7, P=1.1x10(-4)) for biochemically loss-of-function (bLOF) variants. We replicated the enrichment in rare predicted LOF (pLOF) variants at 13 influenza susceptibility loci involved in TLR3-dependent type I IFN immunity (OR=3.70[95%CI 1.3-8.2], P=2.1x10(-4)). This enrichment was further strengthened by (1) adding the recently reported TYK2 and TLR7 COVID-19 loci, particularly under a recessive model (OR=19.65[95%CI 2.1-2635.4], P=3.4x10(-3)), and (2) considering as pLOF branchpoint variants with potentially strong impacts on splicing among the 15 loci (OR=4.40[9%CI 2.3-8.4], P=7.7x10(-8)). Finally, the patients with pLOF/bLOF variants at these 15 loci were significantly younger (mean age [SD]=43.3 [20.3] years) than the other patients (56.0 [17.3] years; P=1.68x10(-5)).ConclusionsRare variants of TLR3- and TLR7-dependent type I IFN immunity genes can underlie life-threatening COVID-19, particularly with recessive inheritance, in patients under 60 years old

    Correction: Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

    No full text
    International audienc
    corecore